A MEDICINAL PRODUCT AND A METHOD FOR TREATMENT OF SICK CHILDREN WITH COVID-19 AND IN THE POST-COVID PERIOD

RU2025104938APending Publication Date: 2026-09-04FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA SEVERO OSETINSKAYA GOSUDARSTVENNAYA MEDITSINSKAYA ACADA MINISTSTVA ZDRAVOOKHRANENIYA ROSSIJSKOJ FEDERATSII
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
RU2025104938
Authority / Receiving Office
RU · RU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-03-04
Publication Date
2026-09-04
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.

Claims

1. A medicinal product for the treatment of children with COVID-19 and in the post-COVID period, made in the form of a suppository, including interferon alpha-2b, lysozyme and a fat base, characterized in that it additionally contains cholecalciferol (vitamin D3), zinc sulfate monohydrate, succinic acid, inosine, nicotinamide, riboflavin in the following ratio of components, wt.%: Lysozyme hydrochloride 0,175 Cholecalciferol (vitamin D3) 1,500 IU Zinc sulfate monohydrate 1,05 Succinic acid 0,2 Inosine 0,025 Nicotinamide 0,02 Riboflavin 0,004 Fat base 1.5 g Interferon alpha-2b 150,000 IU or 1,000,000 IU 2. A method for treating children with COVID-19 and in the post-COVID period, including basic therapy, characterized in that the patient is administered the medicinal product according to paragraph 1 rectally in the form of a suppository twice a day at intervals of 12 hours for 21 days.